DRUG MECHANISM INDICATIONS CONTRAINDICATIONS SIDE EFFECTS/ NURSING CONSIDERATIONS
CLASSIFICATI OF ACTION ADVERSE
ON EFFECTS
cholestyramine Binds bile acids in Management of - Hypersensitivity - Irritation of Assessment:
the GI tract, primary - Complete biliary the tongue - Assess for contraindications and
PO (adults): 4 forming an hypercholesterol obstruction - Abdominal cautions.
g1-2 times a daily insoluble complex. emia. Pruritis - Some products discomfort - Perform a physical assessment.
(initially, may be Result is increased associated with contain aspartame - Constipatio - Weigh the patient.
increased as clearance of elevated levels of and should be n - Inspect the patient’s skin for
needed/tolerated cholesterol. bile acids. avoided in patients - Nausea color, bruising, and rash.
up to 24g/day in 6 with - Flatulence - Assess neurological status.
divided doses) Therapeutic phenylketonuria. - Vomiting - Monitor pulse and blood
effects: - Rashes pressure.
PO (children): Decreased plasma
- Vitamin A,
240 mg/kg/day in cholesterol and Implementation:
D, and K
2-3 divided doses low-density - Do not administer powdered
deficiency
( not >8 g/day) lipoproteins. agents in dry form.
Decreased pruritis.
- If the patient is taking tablets,
ensure that tablets are not cut,
chewed, or crushed.
- measures.
- Offer support and
encouragement.
- Provide thorough patient teaching
Evaluation:
- Monitor patient response to the
drug.
- Monitor for adverse effects.
- Monitor for the effectiveness of
comfort measures and
compliance with the regimen.
DRUG MECHANISM INDICATIONS CONTRAINDICATIONS SIDE EFFECTS/ NURSING CONSIDERATIONS
CLASSIFICATION OF ACTION ADVERSE
EFFECTS
Colesevalam Binds bile acids Adjunctive therapy to - Hypersensitivity - Constipation Assessment:
in the GI tract. diet and exercise for - Bowel obstruction - dyspepsia - Assess for contraindications and
PO (adults): 3 Result in the reduction of LDL cautions.
tablets twice daily or increased cholesterol in patients - Perform a physical assessment.
6 tablets once daily; clearance of with primary - Weigh the patient.
may be increased to 7 cholesterol, hypercholesterolemia; - Inspect the patient’s skin for
tablets daily. may be used aloe or in color, bruising, and rash.
Therapeutic combination with - Assess neurological status.
effects: HMG-CoA reductase
Decreased inhibitor. Implementation:
cholesterol - Do not administer powdered
agents in dry form.
- If the patient is taking tablets,
ensure that tablets are not cut,
chewed, or crushed.
- Give the drug before meals
- Provide comfort measures.
- Offer support and
encouragement.
- Provide thorough patient
teaching
Evaluation:
- Monitor patient response to the
drug.
- Monitor for adverse effects.
- Monitor for the effectiveness of
comfort measures and
compliance with the regimen.
- Evaluate the effectiveness of the
teaching plan.